TW249754B - - Google Patents

Info

Publication number
TW249754B
TW249754B TW082108901A TW82108901A TW249754B TW 249754 B TW249754 B TW 249754B TW 082108901 A TW082108901 A TW 082108901A TW 82108901 A TW82108901 A TW 82108901A TW 249754 B TW249754 B TW 249754B
Authority
TW
Taiwan
Application number
TW082108901A
Other languages
Chinese (zh)
Original Assignee
Alpha I Biomedicals Inc
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha I Biomedicals Inc, Univ Wayne State filed Critical Alpha I Biomedicals Inc
Application granted granted Critical
Publication of TW249754B publication Critical patent/TW249754B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
TW082108901A 1993-10-26 1993-10-26 TW249754B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/141,013 US5468729A (en) 1993-10-26 1993-10-26 Method for treatment of autoimmune hepatitis

Publications (1)

Publication Number Publication Date
TW249754B true TW249754B (enExample) 1995-06-21

Family

ID=22493765

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082108901A TW249754B (enExample) 1993-10-26 1993-10-26

Country Status (8)

Country Link
US (1) US5468729A (enExample)
AU (1) AU8086894A (enExample)
MY (1) MY115157A (enExample)
PH (1) PH31319A (enExample)
SG (1) SG46620A1 (enExample)
TW (1) TW249754B (enExample)
WO (1) WO1995011696A1 (enExample)
ZA (1) ZA948252B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
NZ532310A (en) 2001-10-05 2007-02-23 Combinatorx Inc Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
US20080003213A1 (en) * 2006-05-22 2008-01-03 Jan Lessem Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ITRM20060584A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
CN102458470B (zh) * 2009-05-08 2016-01-20 赛生制药有限公司 作为疫苗增强剂的α胸腺素肽
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EA027380B1 (ru) 2011-04-29 2017-07-31 Селекта Байосайенсиз, Инк. Наноносители, вырабатывающие иммунную толерантность, для вырабатывания cd8регуляторных т-клеток
KR20240119160A (ko) 2013-05-03 2024-08-06 셀렉타 바이오사이언시즈, 인크. 바람직하지 않은 체액성 면역 반응을 감소시키기 위한 투약 조합물
CA2957808A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
KR102753928B1 (ko) 2017-03-11 2025-01-14 셀렉타 바이오사이언시즈, 인크. 항염증제, 및 면역억제제를 포함하는 합성 나노담체를 사용한 조합 치료와 관련된 방법 및 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
TW224053B (enExample) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
ZA948252B (en) 1996-04-22
SG46620A1 (en) 1998-02-20
AU8086894A (en) 1995-05-22
WO1995011696A1 (en) 1995-05-04
MY115157A (en) 2003-04-30
US5468729A (en) 1995-11-21
PH31319A (en) 1998-07-06
MX9408106A (es) 1997-09-30

Similar Documents

Publication Publication Date Title
EP0643122A3 (enExample)
EP0636901A3 (enExample)
EP0671575A3 (enExample)
DK0607839T3 (enExample)
DK18793A (enExample)
DK53594A (enExample)
EP0661252A3 (enExample)
FR2706927B1 (enExample)
FR2706936B1 (enExample)
FR2706940B1 (enExample)
TW236609B (enExample)
IN182001B (enExample)
ECSDI930124S (enExample)
IN176980B (enExample)
IN177590B (enExample)
IN182357B (enExample)
IN182436B (enExample)
IN182271B (enExample)
ECSDI930120S (enExample)
ECSDI930123S (enExample)
IN176891B (enExample)
ECSDI930144S (enExample)
IN186199B (enExample)
ECSDI930145S (enExample)
ECSDI930150S (enExample)